Division of Neuroscience, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, E-31008, Spain.
Exp Neurol. 2012 Nov;238(1):1-11. doi: 10.1016/j.expneurol.2011.12.013. Epub 2011 Dec 19.
Huntington's disease (HD) is an incurable neurodegenerative disease characterized by abnormal motor movements, personality changes, and early death. HD is caused by a mutation in the IT-15 gene that expands abnormally the number of CAG nucleotide repeats. As a result, the translated protein huntingtin contains disease-causing expansions of glutamines (polyQ) that make it prone to misfold and aggregate. While the gene and mutations that cause HD are known, the mechanisms underlying HD pathogenesis are not. Here we will review the state of knowledge of HD, focusing especially on a hallmark pathological feature-intracellular aggregates of mutant Htt called inclusion bodies (IBs). We will describe the role of IBs in the disease. We speculate that IB formation could be just one component of a broader coping response triggered by misfolded Htt whose efficacy may depend on the extent to which it clears toxic forms of mutant Htt. We will describe how IB formation might be regulated and which factors could determine different coping responses in different subsets of neurons. A differential regulation of IB formation as a function of the cellular context could, eventually, explain part of the neuronal vulnerability observed in HD.
亨廷顿病(HD)是一种无法治愈的神经退行性疾病,其特征是运动异常、人格改变和早逝。HD 是由 IT-15 基因中的突变引起的,该突变导致 CAG 核苷酸重复异常扩增。结果,翻译出的 huntingtin 蛋白含有致病的谷氨酰胺(polyQ)扩展,使其容易错误折叠和聚集。虽然导致 HD 的基因和突变是已知的,但 HD 发病机制的机制尚不清楚。在这里,我们将回顾 HD 的现有知识状态,特别关注突变 Htt 的一个标志性病理特征——称为包涵体(IBs)的细胞内聚集体。我们将描述 IBs 在疾病中的作用。我们推测 IB 的形成可能只是由错误折叠的 Htt 触发的更广泛应对反应的一个组成部分,其效果可能取决于它清除有毒形式的突变 Htt 的程度。我们将描述 IB 的形成如何受到调节,以及哪些因素可以决定不同神经元亚群的不同应对反应。IB 形成的差异调节作为细胞环境的功能,最终可以解释在 HD 中观察到的部分神经元易感性。